Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study.

Jang, Young Rock; Oh, Yoon Ju; Kim, Jin Yong

Jang, Young Rock; Oh, Yoon Ju; Kim, Jin Yong.

Afiliação

Jang YR; Division of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.
Oh YJ; Division of Metabolism and Endocrinology, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.
Kim JY; Division of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Republic of Korea.

Curr Ther Res Clin Exp ; 96: 100675, 2022.

Article em En | MEDLINE | ID: mdl-35601976

Palavras-chave

COVID-19; CT-P59; SARS-CoV-2; regdanvimab; retrospective study

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Curr Ther Res Clin Exp Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google